Recently, this journal published a paper from Marr et al 1 concerning multi-drug intra-arterial chemotherapy (IAC) for intraocular retinoblastoma. In many centres IAC has quickly garnered exciting interest, emerging as a promising, highly effective alternative for globe conserving treatment.2–4 In our institution, IAC with melphalan (IACM) has been performed since June 2008, and topotecan was added in June 2011. Fifty-nine patients have at least 1 year follow-up. Here we report our results obtained with IACM.
Bracco, S., Leonini, S., DE FRANCESCO, S., Cioni, S., Gennari, P., Vallone, I.M., et al. (2013). Intra-arterial chemotherapy with melphalan for intraocular retinoblastoma. BRITISH JOURNAL OF OPHTHALMOLOGY, 97(9), 1219-1221 [10.1136/bjophthalmol-2013-303267].
Intra-arterial chemotherapy with melphalan for intraocular retinoblastoma
LEONINI, SARA;DE FRANCESCO, SONIA;PIU, PIETRO;GALIMBERTI, DANIELA;CAINI, MAURO;DE LUCA, MARIACARLA;TOTI, PAOLO;HADJISTILIANOU, THEODORA;
2013-01-01
Abstract
Recently, this journal published a paper from Marr et al 1 concerning multi-drug intra-arterial chemotherapy (IAC) for intraocular retinoblastoma. In many centres IAC has quickly garnered exciting interest, emerging as a promising, highly effective alternative for globe conserving treatment.2–4 In our institution, IAC with melphalan (IACM) has been performed since June 2008, and topotecan was added in June 2011. Fifty-nine patients have at least 1 year follow-up. Here we report our results obtained with IACM.
| File | Dimensione | Formato | |
|---|---|---|---|
|
13-BJO.print.pdf
non disponibili
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
102.5 kB
Formato
Adobe PDF
|
102.5 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/975345